ClinicalTrials.Veeva

Menu

National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes (EPISTRESS2)

C

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Status

Completed

Conditions

Diabetes Type 1

Treatments

Other: questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT06365255
2022-A01453-40

Details and patient eligibility

About

The EPISTRESS2 study is a one-off cross-sectional epidemiological survey, carried out via an online form in patients with type 1 diabetes followed up by participating investigating centres.

In type 1 diabetes (T1DM), studies on stress and its impact on glycaemia have led to ambiguous results, mainly because there are no solid epidemiological or experimental data in the literature. The aim of this study was to assess the impact of perceived stress on blood glucose levels in a population of subjects with T1DM at 10 national centres.

Enrollment

1,344 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with type 1 diabetes;
  • Do not have a psychiatric pathology;
  • At least 18 years old;
  • Affiliated to the Social Security;
  • Having read the non-opposition form and not objecting to it.

Exclusion criteria

  • Patient who has declared his opposition using the electronic non-opposition form
  • Patient with type 2 diabetes

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems